Dear Friend,

This year Democracy Now! is celebrating our 25th anniversary—that's 25 years of bringing you fearless, independent reporting. Since our very first broadcast in 1996, Democracy Now! has refused to take government or corporate funding, because nothing is more important to us than our editorial independence. But that means we rely on you, our audience, for support. Please donate today in honor of our 25th anniversary and help us stay on air for another 25 years. We can't do our work without you. Right now, a generous donor will even DOUBLE your gift, which means it’ll go twice as far! This is a challenging time for us all, but if you're able to make a donation, please do so today. Thank you and remember, wearing a mask is an act of love.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.


U.S. to Pause Use of Johnson & Johnson COVID-19 Vaccine Amid Reports of Rare Blood Clots

HeadlineApr 13, 2021

U.S. health officials are calling for an immediate pause in the use of Johnson & Johnson’s single-dose COVID-19 vaccine, after six recipients developed a rare complication from blood clots within two weeks of their vaccinations. One woman died, and another has been hospitalized in critical condition. It’s not known if the vaccine caused the disorders. The Centers for Disease Control and Prevention reports as many as 100,000 people regularly die of blood clots each year, and clotting is often a symptom of COVID-19.

On Monday, the U.S. recorded 70,000 new cases as the nation’s COVID-19 death toll passed 562,000. The CDC reports 120 million U.S. residents have received at least one dose of a vaccine.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation